Foundry IntMom Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1GOOGL | ALPHABET INC | Communication Services | $4.20T | 42.23% |
2TSLA | TESLA INC | Consumer Cyclical | $1.43T | 14.38% |
3MU | MICRON TECHNOLOGY INC | Technology | $958.80B | 9.64% |
4INTC | INTEL CORP | Technology | $477.67B | 4.80% |
5LRCX | LAM RESEARCH CORP | Technology | $391.80B | 3.94% |
6SNDK | SANDISK CORP | Technology | $200.63B | 2.02% |
7STX | SEAGATE TECHNOLOGY HOLDINGS PLC | Technology | $176.62B | 1.78% |
8WDC | WESTERN DIGITAL CORP | Technology | $164.49B | 1.65% |
9APP | APPLOVIN CORP | Technology | $142.62B | 1.43% |
10MNST | MONSTER BEVERAGE CORP | Consumer Defensive | $95.36B | 0.96% |
11GM | GENERAL MOTORS CO | Consumer Cyclical | $68.59B | 0.69% |
12WBD | WARNER BROS DISCOVERY INC | Communication Services | $67.37B | 0.68% |
13BE | BLOOM ENERGY CORP | Industrials | $61.14B | 0.61% |
14LITE | LUMENTUM HOLDINGS INC | Technology | $57.01B | 0.57% |
15COHR | COHERENT CORP | Technology | $54.31B | 0.55% |
16CIEN | CIENA CORP | Technology | $53.00B | 0.53% |
17EA | ELECTRONIC ARTS INC | Communication Services | $52.38B | 0.53% |
18TER | TERADYNE INC | Technology | $50.46B | 0.51% |
19RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 0.40% |
20RKLB | ROCKET LAB CORP | Industrials | $39.14B | 0.39% |
21NTRA | NATERA INC | Healthcare | $38.87B | 0.39% |
22TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $37.30B | 0.37% |
23RDDT | REDDIT INC | Communication Services | $34.88B | 0.35% |
24CNC | CENTENE CORP | Healthcare | $32.81B | 0.33% |
25EXPE | EXPEDIA GROUP INC | Industrials | $32.26B | 0.32% |
26ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 0.27% |
27MDB | MONGODB INC | Technology | $25.12B | 0.25% |
28ROIV | ROIVANT SCIENCES LTD | Healthcare | $24.82B | 0.25% |
29UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 0.23% |
30RIVN | RIVIAN AUTOMOTIVE INC | Consumer Cyclical | $22.00B | 0.22% |
31MKSI | MKS INC | Technology | $21.93B | 0.22% |
32FTAI | FTAI AVIATION LTD | Industrials | $21.28B | 0.21% |
33GH | GUARDANT HEALTH INC | Healthcare | $20.67B | 0.21% |
34RGLD | ROYAL GOLD INC | Basic Materials | $16.05B | 0.16% |
35AMKR | AMKOR TECHNOLOGY INC | Technology | $15.60B | 0.16% |
36SITM | SITIME CORP | Technology | $14.65B | 0.15% |
37ALB | ALBEMARLE CORP | Basic Materials | $14.24B | 0.14% |
38ONTO | ONTO INNOVATION INC | Technology | $13.92B | 0.14% |
39BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $13.71B | 0.14% |
40MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $12.76B | 0.13% |
41U | UNITY SOFTWARE INC | Technology | $12.66B | 0.13% |
42DOCN | DIGITALOCEAN HOLDINGS INC | Technology | $12.41B | 0.12% |
43COKE | COCA-COLA CONSOLIDATED INC | Consumer Defensive | $12.03B | 0.12% |
44AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.12% |
45W | WAYFAIR INC | Consumer Cyclical | $11.79B | 0.12% |
46AA | ALCOA CORP | Basic Materials | $11.61B | 0.12% |
47VICR | VICOR CORP | Technology | $10.83B | 0.11% |
48FROG | JFROG LTD | Technology | $10.72B | 0.11% |
49ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $10.47B | 0.11% |
50GMED | GLOBUS MEDICAL INC | Healthcare | $10.45B | 0.11% |
51HUT | HUT 8 CORP | Financial Services | $10.30B | 0.10% |
52GSAT | GLOBALSTAR INC | Communication Services | $10.20B | 0.10% |
53APGE | APOGEE THERAPEUTICS INC | Healthcare | $10.10B | 0.10% |
54VSAT | VIASAT INC | Technology | $9.76B | 0.10% |
55HL | HECLA MINING CO | Basic Materials | $9.61B | 0.10% |
56MSGS | MADISON SQUARE GARDEN SPORTS CORP | Communication Services | $9.56B | 0.10% |
57KYMR | KYMERA THERAPEUTICS INC | Healthcare | $9.52B | 0.10% |
58WULF | TERAWULF INC | Financial Services | $9.00B | 0.09% |
59IONS | IONIS PHARMACEUTICALS INC | Healthcare | $8.99B | 0.09% |
60COMP | COMPASS INC | Technology | $8.97B | 0.09% |
61VIAV | VIAVI SOLUTIONS INC | Technology | $8.93B | 0.09% |
62PRAX | PRAXIS PRECISION MEDICINES INC | Healthcare | $8.77B | 0.09% |
63SYRE | SPYRE THERAPEUTICS INC | Healthcare | $8.70B | 0.09% |
64FORM | FORMFACTOR INC | Technology | $8.23B | 0.08% |
65PL | PLANET LABS PBC | Industrials | $8.01B | 0.08% |
66APLD | APPLIED DIGITAL CORP | Financial Services | $7.37B | 0.07% |
67PACS | PACS GROUP INC | Healthcare | $7.30B | 0.07% |
68CIFR | CIPHER DIGITAL INC | Financial Services | $7.18B | 0.07% |
69ENS | ENERSYS | Industrials | $7.18B | 0.07% |
70LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.07% |
71COGT | COGENT BIOSCIENCES INC | Healthcare | $6.68B | 0.07% |
72VFC | V F CORP | Consumer Cyclical | $6.65B | 0.07% |
73VSXY | VICTORIA'S SECRET & CO | Consumer Cyclical | $6.47B | 0.07% |
74LUMN | LUMEN TECHNOLOGIES INC | Communication Services | $6.47B | 0.07% |
75PATH | UIPATH INC | Technology | $6.30B | 0.06% |
76M | MACY'S INC | Consumer Cyclical | $6.23B | 0.06% |
77QBTS | D-WAVE QUANTUM INC | Technology | $6.19B | 0.06% |
78KRMN | KARMAN HOLDINGS INC | Industrials | $6.12B | 0.06% |
79ERAS | ERASCA INC | Healthcare | $5.96B | 0.06% |
80LYFT | LYFT INC | Technology | $5.89B | 0.06% |
81ENVA | ENOVA INTERNATIONAL INC | Financial Services | $5.79B | 0.06% |
82DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | $5.77B | 0.06% |
83PRM | PERIMETER SOLUTIONS INC | Basic Materials | $5.61B | 0.06% |
84ORKA | ORUKA THERAPEUTICS INC | Healthcare | $5.59B | 0.06% |
85SSRM | SSR MINING INC | Basic Materials | $5.31B | 0.05% |
86TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.05% |
87XMTR | XOMETRY INC | Industrials | $5.18B | 0.05% |
88LMND | LEMONADE INC | Financial Services | $5.16B | 0.05% |
89SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $5.10B | 0.05% |
90LAUR | LAUREATE EDUCATION INC | Consumer Defensive | $5.10B | 0.05% |
91VCYT | VERACYTE INC | Healthcare | $4.72B | 0.05% |
92RGTI | RIGETTI COMPUTING INC | Technology | $4.69B | 0.05% |
93LFST | LIFESTANCE HEALTH GROUP INC | Healthcare | $4.49B | 0.05% |
94LIVN | LIVANOVA PLC | Healthcare | $4.43B | 0.04% |
95CELC | CELCUITY INC | Healthcare | $4.31B | 0.04% |
96COCO | VITA COCO COMPANY INC | Consumer Defensive | $4.18B | 0.04% |
97HCC | WARRIOR MET COAL INC | Basic Materials | $4.17B | 0.04% |
98CENX | CENTURY ALUMINUM CO | Basic Materials | $4.11B | 0.04% |
99LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.04% |
100DYN | DYNE THERAPEUTICS INC | Healthcare | $3.92B | 0.04% |
101LASR | NLIGHT INC | Technology | $3.91B | 0.04% |
102LBRT | LIBERTY ENERGY INC | Energy | $3.89B | 0.04% |
103RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.04% |
104ALMS | ALUMIS INC | Healthcare | $3.65B | 0.04% |
105ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.56B | 0.04% |
106MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.56B | 0.04% |
107GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | $3.45B | 0.03% |
108RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.03% |
109HP | HELMERICH & PAYNE INC | Energy | $3.41B | 0.03% |
110FSLY | FASTLY INC | Technology | $3.24B | 0.03% |
111ONDS | ONDAS INC | Technology | $3.23B | 0.03% |
112WK | WORKIVA INC | Technology | $3.21B | 0.03% |
113SHOO | STEVEN MADDEN LTD | Consumer Cyclical | $3.17B | 0.03% |
114GRAL | GRAIL INC | Healthcare | $3.12B | 0.03% |
115AXTI | AXT INC | Technology | $3.00B | 0.03% |
116MBX | MBX BIOSCIENCES INC | Healthcare | $2.99B | 0.03% |
117DAN | DANA INC | Consumer Cyclical | $2.87B | 0.03% |
118TDC | TERADATA CORP | Technology | $2.87B | 0.03% |
119AEO | AMERICAN EAGLE OUTFITTERS INC | Consumer Cyclical | $2.85B | 0.03% |
120RUN | SUNRUN INC | Technology | $2.83B | 0.03% |
121VERA | VERA THERAPEUTICS INC | Healthcare | $2.76B | 0.03% |
122VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.03% |
123BTU | PEABODY ENERGY CORP | Basic Materials | $2.73B | 0.03% |
124ESTA | ESTABLISHMENT LABS HOLDINGS INC | Healthcare | $2.72B | 0.03% |
125ANDE | ANDERSONS INC | Consumer Defensive | $2.70B | 0.03% |
126KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.03% |
127NGVT | INGEVITY CORP | Basic Materials | $2.66B | 0.03% |
128FLNC | FLUENCE ENERGY INC | Utilities | $2.59B | 0.03% |
129TARS | TARSUS PHARMACEUTICALS INC | Healthcare | $2.58B | 0.03% |
130IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.03% |
131SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.02% |
132ATRO | ASTRONICS CORP | Industrials | $2.41B | 0.02% |
133ROG | ROGERS CORP | Technology | $2.36B | 0.02% |
134PLUS | EPLUS INC | Technology | $2.33B | 0.02% |
135NKTR | NEKTAR THERAPEUTICS | Healthcare | $2.31B | 0.02% |
136PVLA | PALVELLA THERAPEUTICS INC | Healthcare | $2.26B | 0.02% |
137MLYS | MINERALYS THERAPEUTICS INC | Healthcare | $2.23B | 0.02% |
138SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.02% |
139DHC | DIVERSIFIED HEALTHCARE TRUST | Real Estate | $2.22B | 0.02% |
140IMAX | IMAX CORP | Communication Services | $2.15B | 0.02% |
141MD | PEDIATRIX MEDICAL GROUP INC | Healthcare | $2.15B | 0.02% |
142AXGN | AXOGEN INC | Healthcare | $2.12B | 0.02% |
143AVAH | AVEANNA HEALTHCARE HOLDINGS INC | Healthcare | $2.11B | 0.02% |
144OMCL | OMNICELL INC | Healthcare | $2.09B | 0.02% |
145GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | $2.07B | 0.02% |
146RAPP | RAPPORT THERAPEUTICS INC | Healthcare | $2.04B | 0.02% |
147NUVB | NUVATION BIO INC | Healthcare | $2.03B | 0.02% |
148SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.02% |
149INFQ | INFLEQTION INC | Technology | $1.98B | 0.02% |
150KSS | KOHLS CORP | Consumer Cyclical | $1.96B | 0.02% |
151DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.02% |
152TYRA | TYRA BIOSCIENCES INC | Healthcare | $1.91B | 0.02% |
153NEO | NEOGENOMICS INC | Healthcare | $1.90B | 0.02% |
154NGL | NGL ENERGY PARTNERS LP | Energy | $1.89B | 0.02% |
155ZBIO | ZENAS BIOPHARMA INC | Healthcare | $1.86B | 0.02% |
156ALGT | ALLEGIANT TRAVEL CO | Industrials | $1.86B | 0.02% |
157VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | $1.86B | 0.02% |
158AMR | ALPHA METALLURGICAL RESOURCES INC | Basic Materials | $1.83B | 0.02% |
159STOK | STOKE THERAPEUTICS INC | Healthcare | $1.81B | 0.02% |
160SONO | SONOS INC | Technology | $1.80B | 0.02% |
161ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.02% |
162HYMC | HYCROFT MINING HOLDING CORP | Basic Materials | $1.74B | 0.02% |
163BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.02% |
164FIGS | FIGS INC | Consumer Cyclical | $1.72B | 0.02% |
165TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.02% |
166ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.02% |
167FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.02% |
168TE | T1 ENERGY INC | Industrials | $1.63B | 0.02% |
169PUMP | PROPETRO HOLDING CORP | Energy | $1.59B | 0.02% |
170MAZE | MAZE THERAPEUTICS INC | Healthcare | $1.56B | 0.02% |
171SKYT | SKYWATER TECHNOLOGY INC | Technology | $1.54B | 0.02% |
172SEPN | SEPTERNA INC | Healthcare | $1.51B | 0.02% |
173TBLA | TABOOLACOM LTD | Communication Services | $1.44B | 0.01% |
174KMTS | KESTRA MEDICAL TECHNOLOGIES LTD | Healthcare | $1.43B | 0.01% |
175GCT | GIGACLOUD TECHNOLOGY INC | Technology | $1.40B | 0.01% |
176REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.01% |
177BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.01% |
178FBYD | FALCON'S BEYOND GLOBAL INC | Industrials | $1.35B | 0.01% |
179ATEC | ALPHATEC HOLDINGS INC | Healthcare | $1.31B | 0.01% |
180XNCR | XENCOR INC | Healthcare | $1.30B | 0.01% |
181DCH | DAUCH CORP | Consumer Cyclical | $1.29B | 0.01% |
182INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.01% |
183TTI | TETRA TECHNOLOGIES INC | Energy | $1.25B | 0.01% |
184CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | $1.25B | 0.01% |
185HLF | HERBALIFE LTD | Consumer Defensive | $1.24B | 0.01% |
186NBR | NABORS INDUSTRIES LTD | Energy | $1.24B | 0.01% |
187IRMD | IRADIMED CORP | Healthcare | $1.24B | 0.01% |
188AMRC | AMERESCO INC | Industrials | $1.22B | 0.01% |
189AORT | ARTIVION INC | Healthcare | $1.22B | 0.01% |
190DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.19B | 0.01% |
191XPEL | XPEL INC | Consumer Cyclical | $1.19B | 0.01% |
192SVRA | SAVARA INC | Healthcare | $1.13B | 0.01% |
193CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | $1.13B | 0.01% |
194NUTX | NUTEX HEALTH INC | Healthcare | $1.12B | 0.01% |
195WVE | WAVE LIFE SCIENCES LTD | Healthcare | $1.12B | 0.01% |
196UPWK | UPWORK INC | Industrials | $1.12B | 0.01% |
197EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.01% |
198RHLD | RESOLUTE HOLDINGS MANAGEMENT INC | Industrials | $1.10B | 0.01% |
199GOLD | GOLDCOM INC | Financial Services | $1.09B | 0.01% |
200JBIO | JADE BIOSCIENCES INC | Healthcare | $1.03B | 0.01% |
201AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.01% |
202BIOA | BIOAGE LABS INC | Healthcare | $1.01B | 0.01% |
203OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | $1.00B | 0.01% |
204FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.01% |
205ABX | ABACUS GLOBAL MANAGEMENT INC | Financial Services | $994M | 0.01% |
206ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.01% |
207LWLG | LIGHTWAVE LOGIC INC | Basic Materials | $960M | 0.01% |
208ANNX | ANNEXON INC | Healthcare | $950M | 0.01% |
209FTK | FLOTEK INDUSTRIES INC | Energy | $947M | 0.01% |
210PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | $873M | 0.01% |
211AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.01% |
212UAMY | UNITED STATES ANTIMONY CORP | Basic Materials | $809M | 0.01% |
213ACRS | ACLARIS THERAPEUTICS INC | Healthcare | $793M | 0.01% |
214DSGN | DESIGN THERAPEUTICS INC | Healthcare | $785M | 0.01% |
215BBNX | BETA BIONICS INC | Healthcare | $771M | 0.01% |
216RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $750M | 0.01% |
217CSTL | CASTLE BIOSCIENCES INC | Healthcare | $733M | 0.01% |
218CLYM | CLIMB BIO INC | Healthcare | $727M | 0.01% |
219CBLL | CERIBELL INC | Healthcare | $710M | 0.01% |
220OMER | OMEROS CORP | Healthcare | $701M | 0.01% |
221MAMA | MAMA'S CREATIONS INC | Consumer Defensive | $700M | 0.01% |
222BALY | BALLY'S CORP | Consumer Cyclical | $688M | 0.01% |
223LPTH | LIGHTPATH TECHNOLOGIES INC | Technology | $657M | 0.01% |
224FEIM | FREQUENCY ELECTRONICS INC | Technology | $650M | 0.01% |
225TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.01% |
226ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.01% |
227NVRI | ENVIRI CORP | Industrials | $643M | 0.01% |
228AENT | ALLIANCE ENTERTAINMENT HOLDING CORP | Communication Services | $641M | 0.01% |
229FET | FORUM ENERGY TECHNOLOGIES INC | Energy | $593M | 0.01% |
230PACK | RANPAK HOLDINGS CORP | Consumer Cyclical | $583M | 0.01% |
231STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.01% |
232ANGO | ANGIODYNAMICS INC | Healthcare | $558M | 0.01% |
233IMMX | IMMIX BIOPHARMA INC | Healthcare | $558M | 0.01% |
234RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.01% |
235RLMD | RELMADA THERAPEUTICS INC | Healthcare | $550M | 0.01% |
236NPCE | NEUROPACE INC | Healthcare | $548M | 0.01% |
237ELA | ENVELA CORP | Consumer Cyclical | $547M | 0.01% |
238XMAX | XMAX INC | Consumer Cyclical | $541M | 0.01% |
239CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | $532M | 0.01% |
240ZURA | ZURA BIO LTD | Healthcare | $518M | 0.01% |
241MNRO | MONRO INC | Consumer Cyclical | $509M | 0.01% |
242MG | MISTRAS GROUP INC | Industrials | $500M | 0.01% |
243NRC | NRC HEALTH | Healthcare | $491M | 0.00% |
244AMCX | AMC GLOBAL MEDIA INC | Communication Services | $461M | 0.00% |
245DIN | DINE BRANDS GLOBAL INC | Consumer Cyclical | $456M | 0.00% |
246KYTX | KYVERNA THERAPEUTICS INC | Healthcare | $453M | 0.00% |
247ALTO | ALTO INGREDIENTS INC | Basic Materials | $453M | 0.00% |
248MATV | MATIV HOLDINGS INC | Basic Materials | $442M | 0.00% |
249BETR | BETTER HOME & FINANCE HOLDING CO | Financial Services | $442M | 0.00% |
250PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.00% |
251ASMB | ASSEMBLY BIOSCIENCES INC | Healthcare | $426M | 0.00% |
252TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.00% |
253IMXI | INTERNATIONAL MONEY EXPRESS INC | Technology | $404M | 0.00% |
254ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.00% |
255EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.00% |
256DMAC | DIAMEDICA THERAPEUTICS INC | Healthcare | $393M | 0.00% |
257UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.00% |
258ELMD | ELECTROMED INC | Healthcare | $349M | 0.00% |
259CV | CAPSOVISION INC | Healthcare | $335M | 0.00% |
260VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.00% |
261TWIN | TWIN DISC INC | Industrials | $326M | 0.00% |
262VELO | VELO3D INC | Technology | $316M | 0.00% |
263ZUMZ | ZUMIEZ INC | Consumer Cyclical | $315M | 0.00% |
264LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $311M | 0.00% |
265BKTI | BK TECHNOLOGIES CORP | Technology | $307M | 0.00% |
266OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $302M | 0.00% |
267DBI | DESIGNER BRANDS INC | Consumer Cyclical | $290M | 0.00% |
268ISBA | ISABELLA BANK CORP | Financial Services | $288M | 0.00% |
269SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.00% |
270SRZN | SURROZEN INC | Healthcare | $255M | 0.00% |
271ASYS | AMTECH SYSTEMS INC | Technology | $242M | 0.00% |
272DUOT | DUOS TECHNOLOGIES GROUP INC | Technology | $241M | 0.00% |
273GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.00% |
274USAU | US GOLD CORP | Basic Materials | $235M | 0.00% |
275RDNW | RIDENOW GROUP INC | Consumer Cyclical | $229M | 0.00% |
276KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.00% |
277LTRX | LANTRONIX INC | Technology | $207M | 0.00% |
278FCAP | FIRST CAPITAL INC | Financial Services | $205M | 0.00% |
279FOCL | FOCAL INC | Healthcare | $204M | 0.00% |
280EGAN | EGAIN CORP | Technology | $180M | 0.00% |
281INFU | INFUSYSTEM HOLDINGS INC | Healthcare | $180M | 0.00% |
282STRS | STRATUS PROPERTIES INC | Real Estate | $165M | 0.00% |
283KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.00% |
284OWLT | OWLET INC | Healthcare | $162M | 0.00% |
285AP | AMPCO PITTSBURGH CORP | Industrials | $156M | 0.00% |
286VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.00% |
287SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.00% |
288WYY | WIDEPOINT CORP | Technology | $115M | 0.00% |
289TRT | TRIO-TECH INTERNATIONAL | Technology | $103M | 0.00% |
290CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.00% |
291INTG | INTERGROUP CORP | Consumer Cyclical | $84M | 0.00% |
292NRXS | NEURAXIS INC | Healthcare | $84M | 0.00% |
293VNCE | VINCE HOLDING CORP | Consumer Cyclical | $83M | 0.00% |
294BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.00% |
295RGS | REGIS CORP | Consumer Cyclical | $74M | 0.00% |
296LONA | LEONABIO INC | Healthcare | $68M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $9.95T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 89% toward Growth. +2% unclassified (31 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
Required>= 75.0%Actual48.8%Margin-26.2%No more than 25% of total assets may be invested in the securities of any one issuer.
Required<= 25.0%Actual42.2%Margin-17.2%The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual46.1%Margin-21.1%
At least 50% of total assets must sit in cash, government securities, other RICs, and other securities limited to 5% of assets and 10% of the issuer's voting securities per issuer.
Required>= 50.0%Actual48.8%Margin-1.2%Arithmetically entailed by '40 Act 5(b)(1) diversification (75%/5% asset leg) — it cannot fail independently, so it is reported outside the tally rather than counted as a separate check.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 50.6% | 14.9% |
| 3 yearsp.a. | 43.7% | 22.3% |
| 5 yearsp.a. | 18.7% | 6.1% |
| 10 yearsp.a. | 18.3% | 0.5% |
| Since inceptionp.a. | 11.4% | 2.9% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 29.3% | 20.2% |
| 2025 | 34.8% | -5.1% |
| 2024 | 61.6% | 56.2% |
| 2023 | 11.4% | -22.4% |
| 2022 | -20.0% | 10.6% |
| 2021 | -0.9% | -27.1% |
| 2020 | 40.5% | -9.7% |
| 2019 | 25.2% | -6.4% |
| 2018 | -4.9% | 10.5% |
| 2017 | 26.0% | 10.4% |
| 2016 | 5.1% | -19.1% |
| 2015 | 2.2% | 17.0% |
| 2014 | 17.0% | 4.7% |
| 2013 | 26.3% | -14.1% |
| 2012 | 16.7% | 2.9% |
| 2011 | -1.6% | 4.5% |
| 2010 | 28.9% | 9.0% |
| 2009 | 31.1% | -3.4% |
| 2008 | -39.1% | 13.6% |
| 2007 | 27.1% | 26.3% |
| 2006 | -0.1% | -12.1% |
| 2005 | 14.8% | 3.7% |
| 2004 | 7.6% | -3.7% |
| 2003 | 38.0% | -11.2% |
| 2002 | -11.3% | 30.2% |
| 2001 | -14.1% | 14.3% |
| 2000 | -36.5% | -37.7% |
| 1999 | 89.9% | 89.6% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry IntMom Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a IntMom signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.